DE69925736D1 - Lupus antikoagulant-antikörper gegen die f1 region von prothrombin - Google Patents

Lupus antikoagulant-antikörper gegen die f1 region von prothrombin

Info

Publication number
DE69925736D1
DE69925736D1 DE69925736T DE69925736T DE69925736D1 DE 69925736 D1 DE69925736 D1 DE 69925736D1 DE 69925736 T DE69925736 T DE 69925736T DE 69925736 T DE69925736 T DE 69925736T DE 69925736 D1 DE69925736 D1 DE 69925736D1
Authority
DE
Germany
Prior art keywords
prothrombin
region
lupus
antikoagulant
antibody against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925736T
Other languages
English (en)
Other versions
DE69925736T2 (de
Inventor
Thomas Exner
Michael Kraus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Therapeutics Ltd
Siemens Healthcare Diagnostics Products GmbH
Original Assignee
Gradipore Ltd
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gradipore Ltd, Dade Behring Marburg GmbH filed Critical Gradipore Ltd
Publication of DE69925736D1 publication Critical patent/DE69925736D1/de
Application granted granted Critical
Publication of DE69925736T2 publication Critical patent/DE69925736T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69925736T 1998-07-10 1999-07-09 Lupus antikoagulant-antikörper gegen die f1 region von prothrombin Expired - Lifetime DE69925736T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP460398 1998-07-10
AUPP4603A AUPP460398A0 (en) 1998-07-10 1998-07-10 Lupus anticoagulant
PCT/AU1999/000556 WO2000002925A1 (en) 1998-07-10 1999-07-09 Lupus anticoagulant antibody to f1 region of prothrombin

Publications (2)

Publication Number Publication Date
DE69925736D1 true DE69925736D1 (de) 2005-07-14
DE69925736T2 DE69925736T2 (de) 2006-03-16

Family

ID=3808841

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925736T Expired - Lifetime DE69925736T2 (de) 1998-07-10 1999-07-09 Lupus antikoagulant-antikörper gegen die f1 region von prothrombin

Country Status (8)

Country Link
EP (1) EP1097174B1 (de)
JP (1) JP2002520012A (de)
AT (1) ATE297410T1 (de)
AU (1) AUPP460398A0 (de)
CA (1) CA2334078A1 (de)
DE (1) DE69925736T2 (de)
ES (1) ES2241292T3 (de)
WO (1) WO2000002925A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244574B2 (en) 2001-03-19 2007-07-17 Eisai Co., Ltd Method of assaying lupus anticoagulant and assay reagent
ES2857551T3 (es) 2017-06-08 2021-09-29 Siemens Healthcare Diagnostics Products Gmbh Calibración de anticoagulante lúpico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903930A1 (en) * 1989-11-06 1991-05-08 Akzo Nv Immunoassays for and monoclonal antibodies to prothrombin¹activation peptides and their degradation products
WO1991017177A1 (en) * 1990-05-04 1991-11-14 Baxter Diagnostics Inc. High affinity antibodies to small peptides

Also Published As

Publication number Publication date
ATE297410T1 (de) 2005-06-15
EP1097174A1 (de) 2001-05-09
EP1097174B1 (de) 2005-06-08
JP2002520012A (ja) 2002-07-09
AUPP460398A0 (en) 1998-08-06
EP1097174A4 (de) 2002-08-14
WO2000002925A1 (en) 2000-01-20
ES2241292T3 (es) 2005-10-16
CA2334078A1 (en) 2000-01-20
DE69925736T2 (de) 2006-03-16

Similar Documents

Publication Publication Date Title
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
ATE339507T1 (de) Erythropoietin-analog-menschliches serum-albumin fusionsprotein
ATE327511T1 (de) Proteom-analyseverfahren
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
DK0749325T3 (da) Bispecifikke molekyler med klinisk anvendelse
EA200000449A1 (ru) Модифицированные витамины к-зависимые полипептиды
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
ATE457459T1 (de) Homogene immunoassays für mehrere allergene
ATE264863T1 (de) 28-epirapaloge
ATE328101T1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
AU5055593A (en) Antibodies specific for HIV
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
NO20051715L (no) HCV assay
ATE234467T1 (de) Immunoassay von vollblutproben
ES2157979T3 (es) Titulacion inmunologica competitiva por medio de una proteina de union utilizada en una estructura de anticuerpos multiclonal.
ES2144604T3 (es) Inmunosubstraccion electroforetica capilar para clasificar y determinar las proteinas m.
DE69925736D1 (de) Lupus antikoagulant-antikörper gegen die f1 region von prothrombin
NO821101L (no) Reagens for optisk bestemmelse av blodkoagulasjonsforholdet
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
DE3585049D1 (de) Monoklonale antikoerper.
ATE304712T1 (de) Thrombozyten-aktivierten vollblutgerinnungszeit
ATE250084T1 (de) Typ i prokollagen aminoterminales propeptid, dessen antikörper und testverfahren unter verwendung davon

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GRADIPORE LTD., NORTH RYDE, NEUSUEDWALES, AU

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, , DE